Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Spain
Manufacturing
Rovi warns analyst profit consensus is 10% to 15% too high
Spanish CDMO Rovi is part of a parade of biopharma contractors struggling to keep their manufacturing businesses growing in a post-COVID world.
Fraiser Kansteiner
Feb 13, 2025 9:58am
Grifols deflects private equity firm's potential takeover offer
Nov 20, 2024 10:13am
Teva inks cancer biosimilar marketing pact with mAbxience
Apr 4, 2024 10:33am
EMA halts manufacturing after inspection of Serra Pamies plant
Aug 22, 2023 1:54pm
Grifols is the latest drugmaker to succumb to the layoff trend
Feb 15, 2023 5:56pm
FDA hits Spanish drug substance maker Bioiberica with a Form 483
Jun 16, 2022 10:50am